Why investors in Twist's series B think silicon will speed up gene synthesis
By -- Samantha McGirr | Jun 2, 2014 | 7:00 AM GMT
Editor's Note: This article was updated on Sep 19, 2016 at 12:25 PM GMT
Investors in Twist Bioscience Corp.'s $26 million series B round expect the company's 10,000-well silicon platform will enable faster, cheaper and more accurate DNA synthesis than traditional 96-well plastic plates.
Read the full 310 word article
User Sign In
This article may not be distributed to non-subscribers
PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD